Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/08/2025
Deutsche Bank has upgraded its rating of the European pharmaceutical industry from "sell" to "buy".
Latest
3 m ago
New Focus Technology (01063.HK) announces profit growth, expecting a net profit of approximately 21 million Hong Kong dollars in the medium term, turning losses into profits year-on-year.
4 m ago
Skyworth Group (00751.HK): Skyworth Digital's net profit attributable to shareholders for the first half of the year was 53.59 million yuan, a year-on-year decrease of 70.53%.
4 m ago
China Liang Holdings (02772.HK) issues profit warning, expecting shareholders' net loss of approximately 500 million to 1 billion yuan in the midterm.
5 m ago
Chteau Holdings (06979.HK) releases its interim results with a net profit attributable to shareholders of 575 million yuan, a 23.54% decrease year-on-year.
5 m ago
Rongchang Bioscience (09995.HK) announced its interim results, with a net loss of about 450 million yuan, a decrease of 42.4% year-on-year.
See all latest